weekly weight loss on tirzepatide results after 8 months semaglutide Tirzepatide Weekly Journal, GLP1 Weight

If all these criteria are met at 5mg, there is no reason to escalate to 7.5mg just because the schedule allows it

Acknowledgements The graphs were created using and Illustrator v29.1

Fidalgo, T.M

Tirzepatide is FDA-approved for two indications: chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity, and as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes

Serious but rare side effects include pancreatitis and gallbladder issues

The drug was approved for adults who are obese or overweight with at least one weight-related health issue like high blood pressure